Chemical Compound

Atazanavir sulfate

CAS Registry Number 229975-97-7
Back to search Request a Quote
Atazanavir sulfate chemical structure
Primary Record

Atazanavir sulfate

In stock
9,581 g
Purity
99.4 %
CAS
229975-97-7

Compound Identifiers & Properties

CAS
229975-97-7
PubChem CID
158550
SMILES
CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC.OS(=O)(=O)O
Canonical SMILES
COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C.O=S(=O)(O)O

Names & Synonyms

  • Atazanavir sulfate
  • Reyataz
  • Atazanavir
  • Zrivada
  • 229975-97-7
  • Atazanavir sulphate
  • Atazor
  • Atazanavir so4
  • Atazanavir (sulfate)
  • Atazanaviri sulfas
  • Atazanavirsulfate
  • Reyataz (TN)
  • Atazanavir sulfate [USAN]
  • Atazanavir sulfate RS
  • Atazanavir Bisulfate Salt
  • Atazanavir sulfate CRS
  • 4MT4VIE29P
  • RefChem:54331
  • UNII-4MT4VIE29P
  • Atazanavir (as sulfate)
  • BMS-232632-05
  • atazanavir; sulfuric acid
  • BMS-232632 sulfate
  • AC1L4K4Y
  • MFCD08067748
  • MLS003915641
  • MLS006010199
  • SCHEMBL341700
  • DTXSID401017206
  • orb1310937
  • ATAZANAVIR SO4 [VANDF]
  • ATAZANAVIR SULFATE [MI]
  • 229975-97-7 (sulfate)
  • Atazanavir sulfate (JAN/USAN)
  • ATAZANAVIR SULFATE [JAN]
  • CHEMBL1200678
  • NSC-742546
  • SCHEMBL29362158
  • Atazanavir (sulfate) (Standard)
  • CHEBI:31243
  • AOB5599
  • C38H52N6O7.H2O4S
  • C38H52N6O7.H2SO4
  • C38H54N6O11S
  • CGP-73547
  • DQSGVVGOPRWTKI-QVFAWCHISA-N
  • Atazanavir sulfate (BMS-232632-05)
  • BMS-232632-05, Reyataz
  • DTXCID801475397
  • GLXC-06688
  • HY-17367AR
  • ATAZANAVIR SULFATE [MART.]
  • BMS-232632
  • AMY36999
  • ATAZANAVIR SULFATE [USP-RS]
  • ATAZANAVIR SULFATE [WHO-DD]
  • ATAZANAVIR SULFATE [WHO-IP]
  • CGP73547
  • CGP75176
  • CGP75355
  • EX-A4010
  • KS-00000FO1
  • BMS232632
  • CGP-75136
  • CGP-75176
  • CID158550
  • HY-17367A
  • s1457
  • Atazanavir Sulfate [USP MONOGRAPH]
  • AKOS016000176
  • ATAZANAVIR SULPHATE [EMA EPAR]
  • EVOTAZ COMPONENT ATAZANAVIR SULFATE
  • ACN-029237
  • CCG-270493
  • CS-1890
  • CS-O-30486
  • FA29047
  • NSC 742546
  • 232632, BMS
  • ATAZANAVIR SULFATE [ORANGE BOOK]
  • BMS23263205
  • ATAZANAVIR SULFATE [EP MONOGRAPH]
  • AS-14954
  • ATAZANAVIRI SULFAS [WHO-IP LATIN]
  • BC677640
  • DA-61286
  • N349
  • SMR002544693
  • BMS 232632 05
  • AB0015721
  • C38-H52-N6-O7.H2-O4-S
  • LS-186585
  • A3411
  • A4040
  • ST24030092
  • SW220258-1
  • A10096
  • D01276
  • SBI-0654095.0001
  • Z-3316
  • 111996-EP2272516A2
  • 111996-EP2298761A1
  • 111996-EP2298783A1
  • 975A977
  • A816475
  • 2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-, dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1) (salt)
  • 3-AMINO-3-(3-BENZYLOXY-PHENYL)-PROPIONICACID
  • Q27114238
  • methyl ((5S,10S,11S,14S)-11-benzyl-5-(tert-butyl)-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,8,12-tetraazahexadecan-14-yl)carbamate sulfate
  • Atazanavir sulfate, 99%, HIV protease inhibitors - 10MG 10mg
  • Dimethyl (3S,8S,9S,12S)-9-benzyl-3,12,di-tert-butyl-8-hydroxy-4,11-dioxo-6-(p-2-pyridylbenzyl)-2,5,6,10,13-pentaazatetradecanedioate, sulfate (1:1) (salt)
  • 2,5,6,10,13-Pentaazatetradecanedioic acid, 3-12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((-4-(2-pyridinyl)phenyl)methyl)-, dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1) (salt)
  • methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate;sulfuric acid
  • 2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, 1,14-dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1)
  • 2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1) (salt)
  • 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester
  • Atazanavir Bisulfate Salt; 2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, 1,14-dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1); 2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1) (salt) (9CI); Atazanavir sulfate; Atazor
  • dimethyl (3S,8S,9S,12S)-9-benzyl-3,12-di-tert-butyl-8-hydroxy-4,11-dioxo-6-(4-(2-pyridyl)benzyl)-2,5,6,10,13-pentaazatetradecanedioate sulfate
  • Methyl [(5S,10S,11S,14S)-11-benzyl-5-tert-butyl-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-[[4-(pyridin-2-yl)phenyl]methyl]-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate sulfate
  • methyl N-[(1S)-1-[[(1S,2S)-1-benzyl-2-hydroxy-3-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-[[4-(2-pyridyl)phenyl]methyl]amino]propyl]carbamoyl]-2,2-dimethyl-propyl]carbamate;sulfuric acid
  • Methyl N-[(2S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-[(4-pyridin-2-ylphenyl)methyl]am ino]-1-phenylbutan-2-yl]amino]-3,3-dimethyl-1-oxobutan-2-yl]carbamate sulfate
  • methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate; sulfuric acid
  • Sulfuric acid--methyl [(5S,10S,11S,14S)-11-benzyl-5-tert-butyl-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-{[4-(pyridin-2-yl)phenyl]methyl}-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate (1/1)